The importance of bisphosphonate therapy in maintaining bone mass in men after therapy with teriparatide [human parathyroid hormone(1–34)]

Author： Kurland Etah   Heller Samantha   Diamond Beverly   McMahon Donald   Cosman Felicia   Bilezikian John  

Publisher： Springer Publishing Company

ISSN： 0937-941X

Source： Osteoporosis International, Vol.15, Iss.12, 2004-12, pp. : 992-997

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

CLINICAL EXPERIENCES WITH HUMAN PARATHYROID HORMONE 1–34*

By  

INTERNAL MEDICINE JOURNAL, Vol. 16, Iss. 6, 1986-12 ,pp. : 794-798

John Wiley & Sons Inc

Access to resources Recommend Favorite

Parathyroid hormone analogues in the therapy of osteoporosis

By Müller Markus   Pietschmann Peter  

Wiener klinische Wochenschrift, Vol. 120, Iss. 11-12, 2008-06 ,pp. : 321-324

Springer Publishing Company

Access to resources Recommend Favorite

Therapy of hypoparathyroidism with intact parathyroid hormone

By Rubin M.   Sliney J.   McMahon D.   Silverberg S.   Bilezikian J.  

Osteoporosis International, Vol. 21, Iss. 11, 2010-11 ,pp. : 1927-1934

Springer Publishing Company

Access to resources Recommend Favorite

Maintaining Normal Levels of Ionized Calcium during Citrate-Based Renal Replacement Therapy Is Associated with Stable Parathyroid Hormone Levels

By  

Nephron Clin Pract, Vol. 124, Iss. 1-2, 2013-11 ,pp. : 124-131

Karger

Access to resources Recommend Favorite

Effects of parathyroid hormone alone or in combination with antiresorptive therapy on bone mineral density and fracture risk – a meta-analysis

By Vestergaard P.   Jorgensen N.   Mosekilde L.   Schwarz P.  

Osteoporosis International, Vol. 18, Iss. 1, 2007-01 ,pp. : 45-57

Springer Publishing Company

Access to resources Recommend Favorite